XML 83 R34.htm IDEA: XBRL DOCUMENT v3.20.1
Organization and Description of the Business (Details)
$ in Millions
12 Months Ended
May 09, 2019
USD ($)
shares
Dec. 31, 2019
Number of shares issued per common stock outstanding | shares 0.6906  
Reverse stock split ratio 0.0714 0.0714
Anticipated purchase of common shares upon completion of merger | $ $ 10.0  
Percentage of ownership 76.00%  
AmpliPhi Biosciences Corporation [Member]    
Percentage of ownership 24.00%